Anti-CD20 monoclonal antibody (mAb) therapy and colitis: A case series and review
Sarah Tolaymat, Kanika Sharma, Yusuf Kagzi, Shitiz Sriwastava
Topics & Concepts
MedicineOcrelizumabRituximabAdverse effectCD20NatalizumabIntensive care medicineMultiple sclerosisImmunologyInternal medicineAntibodyMicroscopic ColitisInflammatory Bowel DiseaseCeliac Disease Research and Management